SEP 28 2004
. CoolTouch Inc.
CoolTouch NS-160 Nd:YAG Laser System
510(k) Premarket Notification
510(k) SUMMARY Kor 04a
This 510(k) summary of safety and effectiveness for the CoolTouch NS-160 Nd:YAG
Laser System is submitted in accordance with the requirements of SMDA of 1990 and
follows Office of Device Evaluation guidance concerning the organization and content of
a 510(k) summary.
Applicant: CoolTouch Inc.
Address: 9085 Foothills Boulevard
Roseville, CA 95747
Contact Person: Donald V. Johnson
Vice-President of Operations
Telephone: (916) 677-1912
Facsimile: (916) 677-1901
Date Prepared: April 6. 2004
Device Trade Name: CoolTouch Model NS-160 Nd:YAG Laser System
Common Name: Nd: YAG Surgical Laser
Classification Name: Laser Surgical Instrument.
21 C.F.R. § 878.4810
Legally Marketed Predicate Device: Diomed 810nm Surgical Laser, K023543, K012398
Biolitec Ceralas D10-60 810nm Diode Laser, K030700
Biolitec Ceralas D 980nm Diode Laser, K024088
Description of the CoolTouch The CoolTouch NS-160 Nd:YAG Laser System is an
Nd:YAG Laser Systems: ND:YAG laser producing laser emission at 1320 nm.
The laser consists of two sections: The cabinet, which
houses the power supply, cooling system,
microcontroller and the laser, and the fiber optic.
Intended use of CoolTouch The Coo!Touch NS-160 Nd:YAG Laser System is
Nd:YAG Laser Systems: indicated for the treatment of reflux of the greater
saphenous vein associated with varicose veins and
varicosities.
Nonclinical Performance Data: None

Clinical Performance Data: Clinical data produced results that indicate that the
Coo!Touch Nd:YAG Laser System is effective in the
treatment of reflux of the greater saphenous vein
associated with varicose veins and varicosities.

Conclusion: The CoolTouch NS-160 Laser System is indicated for
the treatment of reflux of the greater saphenous vein
associated with varicose veins and varicosities. The
CoolTouch NS-160 is substantially equivalent to the
predicate devices with the same intended use.

Additional Information: None requested at this time

004

Py
f DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
% &
“Noe Food and Drug Administration
9200 Corporate Boulevard
SEP 28 2004 Rockville MD 20850
Mr. Donald V. Johnson
Vice President of Operations ,
CoolTouch, Inc.
9085 Foothills Boulevard
Roseville, California 95747
Re: K040921
Trade/Device Name: Coo!Touch NS-160 Nd:YAG Laser System
Regulation Number: 21 CFR 878.4810
Regulation Name: Laser surgical instrument for use in general and .
plastic surgery and in dermatology
Regulatory Class: If
Product Code: GEX
Dated: August 16, 2004
Received: August 19, 2004
Dear Mr. Johnson:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration. .

: If your device is classified (see above) into either class II (Special Controls) or class If] (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.

Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2 - Mr. Donald V. Johnson
This letter will allow you to begin marketing your device as described in your Section 5 10(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device
to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please
contact the Office of Compliance at (301) 594-4659. Also, please note the regulation entitled,
"Misbranding by reference to premarket notification” (21CFR Part 807.97). You may obtain
other general information on your responsibilities under the Act from the Division of Small
Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or
(301) 443-6597 or at its Internet address http://www. fda.gov/edrh/dsma/dsmamain.htm!

Sincerely yours,

(og an Ph.D., M.D.
Director
Division of General, Restorative
and Neurological Devices

Office of Device Evaluation

Center for Devices and Radiological Health
Enclosure

INDICATION FOR USE STATEMENT
510(k) Number: K040921
Device Name: Coo!Touch NS-160 Nd:YAG Laser System
Indications for Use:
The CoolTouch NS-160 Nd:YAG Laser System is indicated for the treatment of reflux of the
greater saphenous vein associated with varicose veins and varicosities.
(Please do not write below this line - Continue on another page if needed)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Muuem C. rovont
(Division Sign-Off)
Division of General, Restorative,
and Neurological Devices
072
Prescription use $40(k) Number-on 101273) ye couner Use
(per 21 CFR 801.109)
- 006

